ANUHPHR

Anuh Pharma Limited (ANUHPHR) Stock Analysis

Anuh Pharma Limited is an Indian pharmaceutical company manufacturing APIs and formulations. It produces active ingredients and finished medicines for domestic and export markets. The company operates in the generic pharmaceutical supply chain. It is a listed small-cap pharma stock.

Healthcare › Drug Manufacturers - Specialty & Generic

₹82.00

-4.46% 1W | +4.00% 52W

Market Cap

822 CR

P/E Ratio

18.6

52W High

₹99.5

52W Low

₹67

Div. Yield

1.83%

Beta

0.5

50 DMA

₹84.3

200 DMA

₹79.4

Profit Margin

5.7%

Inst. Own.

⚠️ BREAKDOWN

Fundamentals

Profit & Loss

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	161	150	172	164	138	166	160	198	186	186	197	202	194
Expenses	148	132	148	145	127	149	145	179	176	174	178	182	178
Operating Profit	14	18	24	19	11	17	15	19	10	12	19	20	16
OPM %	9%	12%	14%	12%	8%	10%	9%	9%	6%	6%	10%	10%	8%
Other Income	3	2	4	3	4	3	1	1	3	1	2	-1	3
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2	2	2	2	2	2	2	3	3	3	3	3	2
Profit before tax	15	18	25	20	12	18	13	17	11	10	18	16	17
Tax %	24%	23%	24%	22%	22%	17%	22%	28%	24%	23%	25%	25%	32%
Net Profit	12	14	19	15	10	15	10	12	8	8	13	12	11
EPS in Rs	1.17	1.38	1.91	1.53	0.95	1.50	1.03	1.24	0.83	0.76	1.34	1.17	1.14

Metric	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	284	326	206	238	321	307	432	487	527	647	662	772	779
Expenses	253	289	183	220	291	284	387	439	476	571	600	709	712
Operating Profit	31	38	23	18	30	23	45	47	52	76	62	62	67
OPM %	11%	12%	11%	8%	9%	8%	10%	10%	10%	12%	9%	8%	9%
Other Income	5	4	8	7	5	4	11	5	6	12	9	4	5
Interest	1	1	1	0	1	1	2	2	1	1	1	1	0
Depreciation	3	2	2	2	2	7	15	12	10	9	9	11	11
Profit before tax	32	38	28	23	32	19	39	39	47	78	61	54	60
Tax %	31%	32%	27%	29%	28%	25%	26%	22%	24%	23%	22%	24%
Net Profit	22	26	20	17	23	14	28	31	36	60	47	41	44
EPS in Rs	2.19	2.57	2.00	1.65	2.33	1.43	2.84	3.05	3.61	5.99	4.73	4.10	4.41
Dividend Payout %	27%	24%	31%	42%	29%	48%	26%	29%	28%	21%	16%	37%

Growth — CAGR

Metric	3Y	5Y	10Y
Revenue CAGR	14.0%	12.0%	9.0%
Profit CAGR	3.0%	10.0%	4.0%

Shareholding Pattern

Period

Promoters71.79%

FIIs0.01%

Public28.19%

ANUHPHR

Holdings Analysis

Key strengths & risk signals

Overall

Fundamental

Technical

Risks (4)

OVERVALUED! PEG of 4.33 means expensive relative to growth rate.

RECOVERY MODE! Current price (82.0) above 200-day but below 50-day.

POSITIVE YEAR! Stock gained 4.0% in the last year.

WEAK MOMENTUM! Limited price growth - -4.5% (1 week), -15.2% (1 month), 4.1% (3 months).

Strengths (4)

PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.

BULLISH TREND! 50-day average (84.3) is above 200-day average (79.4) - positive signal.

BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 412,109 vs down days: 119,840. Ratio: 3.44x

LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.

Fundamental & Technical Analysis

64Overall

58Fundamental

71Technical

Fundamental Breakdown

Growth Quality

16/30

Revenue CAGR: 13.5% (GOOD, 11/15). Profit CAGR: 4.3% (SLOW, 5/15).

Profit Margin

3/10

LOW MARGIN! 5.7% profit margin - thin profits.

PEG Valuation

0/10

OVERVALUED! PEG of 4.33 means expensive relative to growth rate.

Dividend Yield

5/10

LOW DIVIDEND! 1.83% yield - minimal income contribution.

Debt to Equity

10/10

VERY LOW DEBT! D/E of 0.00 - excellent financial health.

Public Holding

14/20

MODERATE PUBLIC HOLDING! 29.39% public ownership - balanced ownership structure.

Stability Index

10/10

PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.

Technical Breakdown

Moving Averages

12/10

BULLISH TREND! 50-day average (84.3) is above 200-day average (79.4) - positive signal.

Price Position

2/10

RECOVERY MODE! Current price (82.0) above 200-day but below 50-day.

Trend Pattern

10/20

BREAKDOWN! Stock has broken below support levels - weakness present.

52W Performance

4/10

POSITIVE YEAR! Stock gained 4.0% in the last year.

Volume Sentiment

30/30

BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 412,109 vs down days: 119,840. Ratio: 3.44x

RSI

3/5

NEUTRAL! RSI at 40.1 - balanced momentum.

52W Range

3/5

MID RANGE! Trading at 46.2% of 52W range - neutral zone.

Momentum

2/5

WEAK MOMENTUM! Limited price growth - -4.5% (1 week), -15.2% (1 month), 4.1% (3 months).

Beta

5/5

LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.

Peer Comparison

Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks

Industry peers

Stock	Price	P/E	Profit Margin	Revenue CAGR 5Y	Profit CAGR 5Y	52W Change	Stock Strength	Trendline	YoY Profit	QoQ Profit	YoY Revenue	QoQ Revenue
ANUHPHR	₹82.00	18.6	5.7%	13.5%	4.3%	+4.0%	64	BREAKDOWN	+37.3%	-2.6%	+3.9%	-4.1%
ZIMLAB	₹150.50	183.5	0.9%	-2.5%	-37.9%	+105.9%	57	APPROACHING RESISTANCE	+110.5%	-208.1%	+31.2%	-10.5%
KILITCH	₹241.60	27.4	12.7%	19.2%	42.4%	+41.9%	84	BREAKOUT	-3.3%	-80.0%	+4.2%	-49.9%
AMANTA	₹187.40	45.1	5.0%	3.3%	–	+54.5%	61	BREAKDOWN	-5.7%	-40.0%	+5.4%	-10.6%
WANBURY	₹196.40	12.1	8.6%	8.9%	–	-21.7%	51	APPROACHING SUPPORT	-76.3%	-85.3%	+1.5%	+0.6%
BAFNAPH	₹418.00	127.1	5.5%	9.3%	-0.7%	+152.4%	66	BREAKOUT	-97.1%	-96.3%	-23.1%	-37.0%
VALIANTLAB	₹119.80	42.6	5.2%	-10.7%	–	+41.7%	60	BREAKDOWN	+1,072.2%	+1,072.2%	+146.4%	+25.3%
THEMISMED	₹108.60	25.1	12.1%	-0.4%	-72.8%	-16.1%	53	BREAKDOWN	-273.2%	+176.4%	-10.9%	+13.7%

Data from TradeAlone · Updated daily

No news tagged for ANUHPHR yet.